Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Boston Scientific
BSX
|
+$241M |
| 2 |
eBay
EBAY
|
+$225M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$211M |
| 4 |
Ameren
AEE
|
+$200M |
| 5 |
Kohl's
KSS
|
+$188M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$532M |
| 2 |
Micron Technology
MU
|
+$463M |
| 3 |
Marathon Petroleum
MPC
|
+$239M |
| 4 |
Visa
V
|
+$222M |
| 5 |
Halliburton
HAL
|
+$206M |
Sector Composition
| 1 | Financials | 14.36% |
| 2 | Healthcare | 12.69% |
| 3 | Technology | 12.35% |
| 4 | Industrials | 11.66% |
| 5 | Consumer Discretionary | 11.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKCA
2951
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $310K | ﹤0.01% |
+12,104
| New | +$310K |
|
2952
iShares MSCI ACWI ex US ETF
ACWX
$6.79B
| $309K | ﹤0.01% |
6,224
+1,621
| +35% | +$80.5K |
|
2953
SIGA Technologies
SIGA
$638M
| $309K | ﹤0.01% |
+50,484
| New | +$309K |
|
2954
Tantech Holdings
TANH
$2.84M
| $309K | ﹤0.01% |
12
+9
| +300% | +$232K |
|
2955
Atlanta Braves Holdings Series A
BATRA
$2.87B
| $308K | ﹤0.01% |
+13,547
| New | +$308K |
|
|
MXWL
2956
DELISTED
Maxwell Technologies Inc
MXWL
| $308K | ﹤0.01% |
51,937
+10,582
| +26% | +$62.8K |
|
2957
Sensus Healthcare
SRTS
$52.4M
| $307K | ﹤0.01% |
52,558
-3,939
| -7% | -$23K |
|
2958
Lineage Cell Therapeutics
LCTX
$304M
| $305K | ﹤0.01% |
129,556
-42,718
| -25% | -$101K |
|
2959
OFG Bancorp
OFG
$1.95B
| $303K | ﹤0.01% |
+28,984
| New | +$303K |
|
2960
Manhattan Associates
MANH
$13.1B
| $302K | ﹤0.01% |
7,211
-380
| -5% | -$15.9K |
|
|
IGR
2961
CBRE Global Real Estate Income Fund
IGR
$780M
| $301K | ﹤0.01% |
41,175
-22,851
| -36% | -$167K |
|
2962
iShares US Telecommunications ETF
IYZ
$607M
| $301K | ﹤0.01% |
+11,139
| New | +$301K |
|
2963
Salarius Pharmaceuticals
SLRX
$2.68M
| $301K | ﹤0.01% |
+1
| New | +$301K |
|
|
TGB
2964
Taseko Mines
TGB
$1.13B
| $301K | ﹤0.01% |
261,764
+96,892
| +59% | +$111K |
|
2965
Schwab US Large-Cap Value ETF
SCHV
$13.5B
| $300K | ﹤0.01% |
17,025
-33,141
| -66% | -$584K |
|
2966
Berkshire Hathaway Class A
BRK.A
$1.07T
| $299K | ﹤0.01% |
1
-8
| -89% | -$2.39M |
|
2967
Summit Therapeutics
SMMT
$14.1B
| $299K | ﹤0.01% |
23,178
-76,695
| -77% | -$989K |
|
|
TDF
2968
Templeton Dragon Fund
TDF
$291M
| $299K | ﹤0.01% |
13,450
-8,930
| -40% | -$199K |
|
2969
First Community Corp
FCCO
$215M
| $298K | ﹤0.01% |
12,997
+2,174
| +20% | +$49.8K |
|
2970
BlackRock Limited Duration Income Trust
BLW
$550M
| $297K | ﹤0.01% |
+19,698
| New | +$297K |
|
2971
GATX Corp
GATX
$6.06B
| $297K | ﹤0.01% |
4,339
-14,770
| -77% | -$1.01M |
|
|
MGF
2972
MFS Government Markets Income Trust
MGF
$101M
| $297K | ﹤0.01% |
64,093
-57,659
| -47% | -$267K |
|
2973
Stitch Fix
SFIX
$712M
| $296K | ﹤0.01% |
+14,580
| New | +$296K |
|
|
QD
2974
Qudian
QD
$702M
| $295K | ﹤0.01% |
25,182
-56,523
| -69% | -$662K |
|
|
ELLI
2975
DELISTED
Ellie Mae Inc
ELLI
| $295K | ﹤0.01% |
3,211
-2,727
| -46% | -$251K |
|